Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice

Julius G Juarez, Nadia Harun, Robert Welschinger, Aileen Dela Pena, Stuart M Pitson, Michael Rettig, John F DiPersio, Kenneth F Bradstock, Linda J Bendall

Research output: Contribution to journalArticleResearchpeer-review

89 Citations (Scopus)

Abstract

CXCL12 and VCAM1 retain hematopoietic stem cells (HSC) in the bone marrow but factors mediating HSC egress from the bone marrow to the blood are not known. Sphingosine-1-Phosphate (S1P) receptor 1 (S1P(1)) is expressed on HSC, and S1P facilitates the egress of committed hematopoietic progenitors from the bone marrow into the blood. We show that the S1P gradient between the bone marrow and the blood, and expression of S1P(1), is essential for optimal HSC mobilization by CXCR4 antagonists including AMD3100, and for the trafficking of HSC during steady state hematopoiesis. We also demonstrate that the S1P(1) agonist, SEW2871, increases AMD3100-induced hematopoietic stem and progenitor cell mobilization. These results suggest the combination of a CXCR4 antagonist and a S1P(1) agonist may prove sufficient for mobilizing HSC in normal donors for transplantation purposes, potentially providing a single mobilization procedure and eliminating the need to expose normal donors to granulocyte colony stimulating factor with its associated side effects.
Original languageEnglish
Pages (from-to)707 - 716
Number of pages10
JournalBlood
Volume119
Issue number3
DOIs
Publication statusPublished - 2012
Externally publishedYes

Cite this